[go: up one dir, main page]

NO976065L - Diglucosylated 1,2-diols as mimetics of sialyl-Lewis X and sialyl-Lewis A - Google Patents

Diglucosylated 1,2-diols as mimetics of sialyl-Lewis X and sialyl-Lewis A

Info

Publication number
NO976065L
NO976065L NO976065A NO976065A NO976065L NO 976065 L NO976065 L NO 976065L NO 976065 A NO976065 A NO 976065A NO 976065 A NO976065 A NO 976065A NO 976065 L NO976065 L NO 976065L
Authority
NO
Norway
Prior art keywords
sialyl
lewis
mimetics
diglucosylated
diols
Prior art date
Application number
NO976065A
Other languages
Norwegian (no)
Other versions
NO976065D0 (en
Inventor
Hartmuth Christian Kolb
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO976065D0 publication Critical patent/NO976065D0/en
Publication of NO976065L publication Critical patent/NO976065L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/207Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)

Abstract

Forbindelser med formel (I) HO OH O OH (D OH OH OH der X er resten av en ikke-glykosidisk, alifatisk 1,2-diol; R, er en S-konfigurert metyl substituert med en karboksylrest og en annen substituent; og R2 er hydrogen, CM2alkyl eller C6aryl. Forbindelsene finner anvendelse som mimetika av sialyl-Lewis X og sialyl-Lewis A.Compounds of formula (I) HO OH O OH (D OH OH OH where X is the residue of a non-glycosidic aliphatic 1,2-diol; R is an S-configured methyl substituted with a carboxyl residue and another substituent; and R 2 is hydrogen, CM 2 alkyl or C 6 aryl The compounds find use as mimetics of sialyl-Lewis X and sialyl-Lewis A.

NO976065A 1995-06-29 1997-12-23 Diglucosylated 1,2-diols as mimetics of sialyl-Lewis X and sialyl-Lewis A NO976065L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH191495 1995-06-29
PCT/EP1996/002785 WO1997001569A1 (en) 1995-06-29 1996-06-26 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a

Publications (2)

Publication Number Publication Date
NO976065D0 NO976065D0 (en) 1997-12-23
NO976065L true NO976065L (en) 1998-02-17

Family

ID=4221546

Family Applications (1)

Application Number Title Priority Date Filing Date
NO976065A NO976065L (en) 1995-06-29 1997-12-23 Diglucosylated 1,2-diols as mimetics of sialyl-Lewis X and sialyl-Lewis A

Country Status (19)

Country Link
EP (1) EP0836610A1 (en)
JP (1) JPH11508548A (en)
KR (1) KR19990028543A (en)
CN (1) CN1196731A (en)
AU (1) AU707474B2 (en)
BR (1) BR9609285A (en)
CA (1) CA2224346A1 (en)
CZ (1) CZ419797A3 (en)
EA (1) EA001356B1 (en)
HU (1) HUP9801805A3 (en)
IL (1) IL118740A0 (en)
MX (1) MX9800218A (en)
NO (1) NO976065L (en)
NZ (1) NZ311686A (en)
PL (1) PL324258A1 (en)
SI (1) SI9620099A (en)
SK (1) SK177897A3 (en)
TR (1) TR199701728T1 (en)
WO (1) WO1997001569A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002217999A1 (en) 2000-11-01 2002-05-15 Cor Therapeutics, Inc. Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
EP1534725A2 (en) 2002-05-16 2005-06-01 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
EP1763533B1 (en) 2003-11-19 2008-01-09 GlycoMimetics, Inc. Specific antagonist for both e- and p-selectins
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
ES2375979T3 (en) 2005-08-09 2012-03-07 Glycomimetics, Inc. GLICOMIMETIC INHIBITORS OF PA-IL LECTIN, PA-IIL LECTIN OR BOTH LECTINES OF PSEUDOMONES.
EP2264043B1 (en) * 2005-09-02 2017-11-08 GlycoMimetics, Inc. Heterobifunctional pan-selectin inhibitors
EP1764093A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764095A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
EP1764096A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
EP2074132B1 (en) * 2006-10-12 2013-05-15 GlycoMimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
EP2117561A1 (en) * 2007-02-09 2009-11-18 GlycoMimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
ES2655443T7 (en) 2011-12-22 2021-03-22 Glycomimetics Inc E-selectin antagonist compounds
SI2928476T1 (en) 2012-12-07 2018-06-29 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
CN107108679B (en) 2014-12-03 2020-10-23 糖模拟物有限公司 Heterobifunctional inhibitors of E-selectin and CXCR4 chemokine receptors
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
JP2019524791A (en) 2016-08-08 2019-09-05 グリコミメティクス, インコーポレイテッド Combinations of T cell checkpoint inhibitors with inhibitors of E-selectin or inhibitors of CXCR4 or with heterobifunctional inhibitors of both E-selectin and CXCR4
US11072625B2 (en) 2016-10-07 2021-07-27 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
JP7272956B2 (en) 2017-03-15 2023-05-12 グリコミメティクス, インコーポレイテッド Galactopyranosyl-cyclohexyl derivatives as E-selectin antagonists
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CN111566117A (en) 2017-12-29 2020-08-21 糖模拟物有限公司 Heterobifunctional inhibitors of E-selectin and galectin-3
CN111867601A (en) 2018-03-05 2020-10-30 糖模拟物有限公司 Methods for the treatment of acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
WO1993023031A1 (en) * 1992-05-08 1993-11-25 The Biomembrane Institute Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
CA2100412A1 (en) * 1992-07-15 1994-01-16 Yutaka Yamada Glycolipid derivatives

Also Published As

Publication number Publication date
AU707474B2 (en) 1999-07-08
SK177897A3 (en) 1998-08-05
CA2224346A1 (en) 1997-01-16
TR199701728T1 (en) 1998-03-21
NZ311686A (en) 2000-01-28
EA199800103A1 (en) 1998-08-27
HUP9801805A3 (en) 2002-01-28
HUP9801805A2 (en) 1998-12-28
NO976065D0 (en) 1997-12-23
PL324258A1 (en) 1998-05-11
CZ419797A3 (en) 1998-06-17
SI9620099A (en) 1998-08-31
WO1997001569A1 (en) 1997-01-16
MX9800218A (en) 1998-07-31
BR9609285A (en) 1999-05-11
IL118740A0 (en) 1996-10-16
AU6305396A (en) 1997-01-30
KR19990028543A (en) 1999-04-15
CN1196731A (en) 1998-10-21
EA001356B1 (en) 2001-02-26
JPH11508548A (en) 1999-07-27
EP0836610A1 (en) 1998-04-22

Similar Documents

Publication Publication Date Title
NO976065L (en) Diglucosylated 1,2-diols as mimetics of sialyl-Lewis X and sialyl-Lewis A
FI934426A0 (en) THIAZOLID INDIONERS, FRAMSTAELLNING OCH ANVAENDNING DAERAV
NO970495L (en) Arylthio compounds as anti-bacterial and antiviral agents
DK374083A (en) CYCLOVITAMIN-D COMPOUNDS
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
FI842513A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV FRUKTOSYLDISACKARIDER.
AU4251485A (en) Benzoxazole and benzthiazole derivatives
EP0640586A4 (en) STILBENE DERIVATIVE AND STILBENE ANALOG DERIVATIVE, AND USE OF SUCH DERIVATIVES.
FI823282L (en) OCTAHYDRONAFTALENDERIVATER OCH DERAS FRAMSTAELLNING
DK537389D0 (en) THE GLYCOSIDASE INHIBITOR SALBOSTATIN, ITS PREPARATION AND USE
ATE100132T1 (en) LIQUID CRYSTALLINE, ESPECIALLY FERROELECTRIC LIQUID CRYSTALLINE MIXTURES.
AU541413B2 (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
FI933065A0 (en) REFERENCE TO A FRUIT PROCESSING OF A CLEANING PRODUCT (2.2.2)
AU562515B2 (en) Pyridinecarbinols
AU6293780A (en) Fungicidal :isoxazolyl carboxanilides:
AU547858B2 (en) Azole fungicides
EP0236916A3 (en) N-aryltetrahydrophthalimide derivatives and their precursors
EP0010107A4 (en) DEFENSE AGAINST WATER ORGANISMS.
SE7805863L (en) RIFAMYCIN ASSOCIATIONS
JPS567775A (en) 4-alkoxy-2-pyrrone derivative
GR3005886T3 (en)
NO964735L (en) Adenosine derivatives
ES8506011A1 (en) Derivatives of tetrahydrobenzothiazole and herbicidal compositions containing the same as an active ingredient
IL67360A0 (en) Alpha-azolylglycols and their use as fungicides
ATE244060T1 (en) CATIONIC COMPOSITIONS CONTAINING HYDROXYESTERS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application